Human kallikrein 14 (KLK14) expression in salivary gland tumors

International Journal of Biological Markers

Volumn 25, Issue 1, 2010, Pages 32-37

  Hashem, Nelly N ^a   Mara, Thomas W ^a   Mohamed, Mohamed ^a   Zhang, Irene ^a   Fung, Kevin ^a   Kwan, Keith F ^a   Daley, Thomas D ^a   Diamandis, Eleftherios P ^b   Darling, Mark R ^a  

^a WESTERN UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Kallikreins; Salivary gland tumors; Salivary glands

Indexed keywords

KALLIKREIN 13; KALLIKREIN 14; KALLIKREIN 3; KALLIKREIN 5; KALLIKREIN 6; NEUROPSIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; GENDER; HUMAN; HUMAN TISSUE; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SALIVARY GLAND TUMOR; TUMOR LOCALIZATION;

EID: 77951007902     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500105     Document Type: Article

References (37)

1. Ellis GL, Auclair PL, Gnepp DR. Surgical pathology of the salivary glands. Philadelphia; Toronto: W.B. Saunders Company; 1991.
2. Aro K, Leivo I, Makitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience. Laryngoscope 2007; 118: 258-262 (Pubitemid 351640197)
3. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryng Head Neck 2006; 135: 451-457 (Pubitemid 44292959)
4. Ramsey SD, Berry K, Moinpour C, et al. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 2002; 97: 1228-1234 (Pubitemid 34478127)
5. Hammerlid E, Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 2001; 84: 149-156 (Pubitemid 32113438)
6. Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998; 90: 656-667 (Pubitemid 28222139)
7. Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: The cancer biomarker family. Cancer Lett 2007; 249: 61-79. (Pubitemid 46427999)
8. Borgoño CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 4: 876-890 (Pubitemid 39472954)
9. Emami N, Diamandis EP. New insights into the functional mechanisms and applications of the kallikrein-related peptidase family. Mol Oncol 2007; 1: 269-287 (Pubitemid 350181645)
10. Borgoño CA, Michael IP, Diamandis EP. Human tissue kallikreins: Physiologic roles and applications in cancer. Mol Cancer Res 2004; 2: 257-280 (Pubitemid 39031076)
11. Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006; 387: 643-652 (Pubitemid 43964786)
12. Ben-Izhak O, Laster Z, Araidy S, Nagler RM. TUNEL - an efficient prognosis predictor of salivary malignancies. Br J Cancer 2007; 96: 1101-1106 (Pubitemid 46608309)
13. Nagler RM, Kerner H, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Prognostic role of apoptopic, BCL-2, C-ERBB-2 and P53 tumour markers in salivary gland malignancies. Oncology 2003; 64: 389-398 (Pubitemid 36682953)
14. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 13 expression in salivary gland tumours. Int J Biol Markers 2006; 21: 106-110 (Pubitemid 44210039)
15. Darling MR, Tsai S, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors. Int J Biol Markers 2006; 21: 201-205 (Pubitemid 46165209)
16. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem 2006; 54: 337-342 (Pubitemid 43291278)
17. Darling MR, Tsai S, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 8 expression in salivary gland tumors. Head Neck Pathol 2008; 2: 169-174
18. Eveson JW, Auclair P, Gnepp DR, et al. Salivary gland tumours. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press 2005; 209-282
19. Ellis GL, Auclair PL. Atlas of tumor pathology. Tumors of the salivary glands. 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1996.
20. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor
21. cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993; 85: 200-206
22. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432 (Pubitemid 47206338)
23. Borgono CA, Michael IP, Shaw JL, et al. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J Biol Chem 2007; 282: 2405-2422
24. Hooper JD, Bui LT, Rae FK, et al. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Genomics 2001; 73: 117-122
25. Singh J, Naran A, Misso NL, Rigby PJ, Thompson PJ, Bhoola KD. Expression of kallikrein-related peptidases (KRP/ hK5, 7, 6, 8) in subtypes of human lung carcinoma. Int Immunopharmacol 2008; 8: 300-306
26. Kurlender L, Borgono C, Michael IP, et al. A survey of alternative transcripts of human tissue kallikrein genes. Biochim Biophys Acta 2005; 1755: 1-14. (Pubitemid 40720237)
27. Lundwall A, Band V, Blaber M, et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol Chem 2006; 387: 637-641 (Pubitemid 43964785)
28. Obiezu CV, Diamandis EP. Human tissue kallikrein gene family: Applications in cancer. Cancer Lett 2005; 224: 1-22. (Pubitemid 40720363)
29. Webber MM, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cells invasion. Clin Cancer Res 1995; 1: 1089-1092
30. Petraki CD, Papanastasiou PA, Karavana VN, Diamandis EP. Cellular distribution of human tissue kallikreins: Immunohistochemical localization. Biol Chem 2006; 387: 653-663
31. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-916 (Pubitemid 17147932)
32. Emami N, Diamandis EP. Human tissue kallikreins: A road under construction. Clin Chim Acta 2007; 381: 78-84. (Pubitemid 46719134)
33. Petraki CD, Gregorakis AK, Vaslamatzis MM, et al. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biol 2005; 27: 1-7.
34. Shih I, Salani R, Fiegl M, et al. Ovarian cancer specific kallikrein profile in effusions. Gynecol Oncol 2007; 105: 501-507 (Pubitemid 46590345)
35. Prezas P, Arlt MJ, Victorov P, et al. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 2006; 387: 807-811
36. Prezas P, Scorilas A, Yfanti C, et al. The role of human tissue kallikreins 7 and 8 in intracranial malignancies. Biol Chem 2006; 387: 1607-1612 (Pubitemid 44837586)
37. Luo L, Yousef G, Diamandis EP, Looijenga L, Bjartell A. Human tissue kallikreins and testicular cancer. APMIS 2003; 111: 225-233 (Pubitemid 36566692)